Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Observational Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT 25 mg as Maintenance Therapy Following the Treatment of GERD

NCT07920679 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07920679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Observational Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT 25 mg as Maintenance Therapy Following the Treatment of GERD
Lead sponsor
HK inno.N Corporation
Phase
Observational
Overall status
Recruiting
Start date
August 14, 2025
Completion date
June 30, 2030
Enrollment
12,868 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

maintenance therapy following treatment for gastroesophageal reflux disease(gerd)

Primary endpoints

Registered primary outcome measures; 1 primary.

  • The proportion of study participants with a Korean Gastroesophageal Reflux Disease Questionnaire (GerdQ) score below 8 at Week 24 after administration of K-CAB Tab/K-CAB ODT 25 mg At Week 24 after enrollment

    A GerdQ score below 8 is defined as no recurrence of GERD

Lead sponsor's other trials

HK inno.N Corporation, most recent start first.

Similar trials

Same condition (Gastroesophageal Reflux) and phase, most recent start first.